REGN earnings date and last-quarter result: next report 2026-07-30, last quarter beat, P/E 15.31. Updated 2026-07-23.
Regeneron Pharmaceuticals (REGN) Research Hub
Regeneron Pharmaceuticals (REGN) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 807.67 USD (+0.33%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 15.31, market cap 67.05B. This hub links to the full technical, earnings and options research available for REGN.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 807.67 USD (+0.33%) |
| 52-week range | 594.9 USD – 859.34 USD |
| Trend regime | Range |
| 14-day RSI | 72.4 (Overbought) |
| Trailing P/E | 15.31 |
| Market cap | 67.05B |
| Dividend yield | 0.56% |
| Next earnings | 2026-07-30 |
Available research for REGN
Covered Call on REGN: how it works, illustrative setup around the real 807.67 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on REGN: how it works, illustrative setup around the real 807.67 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on REGN: how it works, illustrative setup around the real 807.67 USD price, max profit/loss, breakeven and when to use it. Educational.
REGN technical analysis: range, last 807.67 USD, RSI 72.4, 52w range 594.9 USD–859.34 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is REGN in?
Regeneron Pharmaceuticals (REGN) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is REGN in an uptrend or downtrend?
As of 2026-10-26, REGN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is REGN's trailing P/E ratio?
REGN's trailing P/E is 15.31, with a market cap of 67.05B. See the earnings research page for full valuation detail.
When does REGN next report earnings?
REGN is next scheduled to report earnings on 2026-07-30.